ASO Visual Abstract: Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients-A Multicenter Propensity Score Analysis.
Francesco AbborettiCéline LambertMarkus SchäferBruno PereiraBertrand Le RoyDiane MègeGuillaume PiessenJohan GagnièreCaroline GronnierStyliani Mantziarinull nullnull nullPublished in: Annals of surgical oncology (2024)
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- end stage renal disease
- ejection fraction
- chronic kidney disease
- lymph node
- squamous cell carcinoma
- newly diagnosed
- computed tomography
- sentinel lymph node
- prognostic factors
- peritoneal dialysis
- rectal cancer
- clinical trial
- image quality
- patient reported outcomes
- contrast enhanced
- patient reported